Most Profitable Biotechnology Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
6.72 B
 0.02 
 1.39 
 0.03 
2GILD Gilead Sciences
5.67 B
(0.06)
 1.83 
(0.11)
3ABBV AbbVie Inc
4.88 B
 0.38 
 0.89 
 0.34 
4GMAB Genmab AS
4.35 B
(0.11)
 2.10 
(0.23)
5REGN Regeneron Pharmaceuticals
3.95 B
 0.25 
 1.11 
 0.27 
6VRTX Vertex Pharmaceuticals
3.62 B
 0.16 
 2.03 
 0.32 
7BNTX BioNTech SE
2.75 B
(0.08)
 2.18 
(0.17)
8BIIB Biogen Inc
1.16 B
(0.05)
 1.70 
(0.08)
9HLN Haleon Plc
1.12 B
 0.02 
 1.45 
 0.03 
10UTHR United Therapeutics
984.8 M
(0.05)
 1.63 
(0.09)
11INCY Incyte
597.6 M
 0.06 
 2.03 
 0.12 
12ALKS Alkermes Plc
519.16 M
 0.08 
 2.89 
 0.24 
13HALO Halozyme Therapeutics
281.59 M
 0.01 
 2.41 
 0.02 
14NBIX Neurocrine Biosciences
249.7 M
 0.13 
 1.63 
 0.20 
15GLPG Galapagos NV ADR
211.7 M
(0.08)
 1.72 
(0.13)
16EXEL Exelixis
207.76 M
(0.01)
 1.74 
(0.02)
17ZYME Zymeworks Common Stock
205.24 M
 0.16 
 3.00 
 0.48 
18NWBO Northwest Biotherapeutics
179.13 M
(0.15)
 3.71 
(0.56)
19BMRN Biomarin Pharmaceutical
167.65 M
(0.08)
 1.53 
(0.12)
20GYRE Gyre Therapeutics
151.03 M
 0.07 
 10.97 
 0.76 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.